Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Introducing the Next Evolution in Ergonomic Seating: Newtral Chairs Now Available
-
VERSES Recognized in Gartner’s 2024 Hype Cycle for Artificial Intelligence Report
-
The Vita Coco Company to Report Second Quarter 2024 Financial Results on July 31, 2024
-
FEARNOT, a Meme Coin, Will Be Initially Listed on CoinW Exchange
-
Doer Market Expands to Accept Expert Blockchain and Crypto Service Providers
-
Sportradar to Release Second Quarter Financial and Operational Results on August 13, 2024
-
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
-
Duos issues update on Duos Edge AI Subsidiary
-
Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024
-
Immutep Receives Regulatory Clearance for Phase I Study of First-in-Class LAG-3 Agonist Antibody Designed to Treat Autoimmune Diseases
-
Comscore Unveils Key Insights in 2024 State of Gaming Report
-
CareCloud, Inc. Partners with DrFirst to Enhance Medication Adherence and Reduce Healthcare Costs
-
Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
-
Transparent Energy Introduces Strategic Advisory Board
-
MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31
-
Playtika Announces Date of Second Quarter 2024 Results Conference Call
-
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion
-
What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk
-
Collective Liquidity hires former JP Morgan Chase executive as Chief Investment Officer
-
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com
-
Priceline and Cover Genius Announce Global Partnership, Launch Technology-Driven Travel Protection for Flights, Hotels, Rental Cars and Packages
-
Sertifi Grows 9-Year Partnership with Davidson Hospitality Group by Enabling Alternative Payment Methods
-
Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
-
Launch Tech USA and CarTechIQ Announce Strategic Partnership for Automotive AI Solutions and Services
-
North Carolina Regional MLS Expands into Georgia
-
New Epic Poem SALEM’S GATE Blends Religion and Philosophy into Mystical Medieval Adventure to Inspire the Spirit
-
FTI Consulting Names William Perlstein as Leader of the Forensic and Litigation Consulting Segment
-
A Creditor Has Petitioned for Valoe’s Bankruptcy
-
Alliance Trust PLC - Net Asset Value
-
GoldMany.org Makes Spectacular Debut on Nasdaq Big Screen in Times Square
-
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
-
Mattr Commences Production at Two New Composite Technologies Facilities, on Time and on Budget
-
Lilium Reaffirms 2026 Target for First Customer Deliveries and Provides Additional Detail on Testing Program
-
Guardforce AI Expands Contracts with Two Major Retail Customers
-
Cellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
-
DeFi Technologies' Subsidiary Valour Inc. Announces Launch of World’s first Exchange Traded Product for the NEAR Protocol Token
-
Enovix to Release Second Quarter 2024 Financial Results on July 31, 2024
-
Bread Financial™ Promotes Gender Equity with $1 Million Gift to the Women’s Sports Foundation®
-
Gauzy’s Advanced Driver Assistance Systems (ADAS) Enhances Public Safety at the 2024 Paris Olympics With More Than 11 Million Expected Visitors
-
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
-
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
-
Form 8.3 - Equals Group PLC
-
Opthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory Board
-
MAJOR SHAREHOLDER ANNOUNCEMENT
-
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
-
Oxford Biomedica announces CFO transition
-
Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
-
NGM Bio Announces $122 Million Series A Financing to Initiate Registrational Trial in Primary Sclerosing Cholangitis and Fund Phase 2 Trial in Hyperemesis Gravidarum
-
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
-
BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application
